Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Clinical trial NCT07691970 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07691970
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus

Start date: 2026-09-01
Primary completion: 2032-12-31
Enrollment: 1072

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.